---
title: CDMO Daily News — November 5, 2026
slug: daily-news-2026-11-05-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: November 5 CDMO daily: Lonza Expands U.S. Operations with Acquisition of Five CDMO Sites from Merck KGaA; Lonza Acquires Merck KGaA's CDMO Business to Enhance…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-11-05-cdmo
published_at: 2026-11-05T00:00:48.002Z
last_updated: 2026-11-05T00:01:45.920Z
---

### [Lonza](/companies/lonza) Expands U.S. Operations with Acquisition of Five CDMO Sites from [Merck KGaA](/companies/merck-kgaa)
- [Lonza](/companies/lonza) will acquire five U.S. manufacturing sites from [Merck KGaA](/companies/merck-kgaa), increasing its U.S. presence from four to nine sites.
- The acquisition adds approximately 1,100 employees and is expected to generate about 250 million Swiss francs in sales by 2028.

**Operational Impact**

This acquisition significantly expands [Lonza](/companies/lonza)'s U.S. manufacturing capabilities, particularly in bioconjugates and viral vectors, enhancing its ability to meet customer demand.

*Source: [Pharmaceutical Executive RSS](https://www.pharmexec.com/view/lonza-acquire-five-us-cdmo-sites-merck-kgaa)*

---

### [Lonza](/companies/lonza) Acquires [Merck KGaA](/companies/merck-kgaa)'s CDMO Business to Enhance US Manufacturing Capacity
- Merck KGaA has agreed to sell its CDMO business to Lonza for a mid-triple-digit million-euro amount, expected to close in mid-2027.
- The acquisition includes operations in California, Wisconsin, and Indiana, enhancing Lonza's capabilities and manufacturing capacity in the US.

**Operational Impact**

This acquisition will expand [Lonza](/companies/lonza)'s US manufacturing capacity, allowing it to better support customers in the biopharmaceutical sector.

*Source: [BioProcess International RSS](https://www.bioxconomy.com/partnering/portfolio-reshuffle-lonza-buys-merck-kgaa-s-cdmo-arm)*

## References

1. [Pharmaceutical Executive RSS — Lonza Expands U.S. Operations with Acquisition of Five CDMO Sites from Merck KGaA](https://www.pharmexec.com/view/lonza-acquire-five-us-cdmo-sites-merck-kgaa)
2. [BioProcess International RSS — Lonza Acquires Merck KGaA's CDMO Business to Enhance US Manufacturing Capacity](https://www.bioxconomy.com/partnering/portfolio-reshuffle-lonza-buys-merck-kgaa-s-cdmo-arm)

Source: https://www.cdmo.directory/posts/daily-news-2026-11-05-cdmo